home / stock / hgen / hgen news

HGEN News and Press, Humanigen Inc. From 09/29/21

Stock Information
Company Name: Humanigen Inc.
Stock Symbol: HGEN
Market: OTC
Website: humanigen.com
Menu
HGEN HGEN Quote HGEN Short HGEN News HGEN Articles HGEN Message Board
Get HGEN Alerts

News, Short Squeeze, Breakout and More Instantly...
HGEN - Humanigen Announces Oral Presentation of Lenzilumab LIVE-AIR Phase 3 Study Results at IDWeek 2021

Lenzilumab significantly improved the likelihood of survival without ventilation (SWOV) by 54% versus standard treatment in hospitalized patients with COVID-19 pneumonia IDWeek is the premier global scientific meeting that brings together infectious disease specialists from the In...
HGEN - Humanigen Announces the European Medicines Agency Has Appointed a Rapporteur and Co-rapporteur as Part of the Process Related to the Planned Submission of a Marketing Authorization Application (MAA) for Lenzilumab

Humanigen plans to submit an MAA under the centralized procedure seeking Conditional Marketing Authorization (CMA) throughout the European Union (EU) for the use of lenzilumab to treat patients hospitalized with COVID-19 pneumonia Humanigen expects to request accelerated assessmen...

HGEN - Humanigen (HGEN) Presents At Global Healthcare Virtual Conference 2021 - Slideshow

The following slide deck was published by Humanigen, Inc. in conjunction with this event. For further details see: Humanigen (HGEN) Presents At Global Healthcare Virtual Conference 2021 - Slideshow

HGEN - Humanigen Announces Participation and Presentation at Multiple Conferences in September

Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ announced that management will present and participate at multiple virtual investor c...
HGEN - ATER, CEI and RLX among mid-day movers

Gainers: IVERIC (NASDAQ:ISEE) +62%. Echo (NASDAQ:ECHO) +53%. Endo International plc (NASDAQ:ENDP) +35%. Affirm (NASDAQ:AFRM) +32%. Elite Education (NASDAQ:EEIQ) +30%. SigmaTron (NASDAQ:SGMA) +25%. Onion Global (NYSE:OG) +21%. Farmmi (NASDAQ:FAMI) +20%. Aterian (NASDAQ:ATER) +19%. Camber Energ...

HGEN - Why Humanigen Stock Is Sinking Today

Shares of Humanigen (NASDAQ: HGEN) were sinking 15.6% lower as of 11:36 a.m. EDT on Friday. The decline came after the clinical-stage biopharmaceutical company announced on Thursday that the U.S. Food and Drug Administration turned down Emergency Use Authorization for lenzilumab in ...

HGEN - IVERIC bio, Endo leads healthcare gainers; Apellis Pharmaceuticals, Mersana Therapeutics among major losers

Gainers: IVERIC bio (NASDAQ:ISEE) +56%, Endo (NASDAQ:ENDP) +46%, NGM Biopharmaceuticals (NASDAQ:NGM) +16%, Arbutus Biopharma (NASDAQ:ABUS) +15%, CareMax (NASDAQ:CMAX) +11%. Losers: Apellis Pharmaceuticals (NASDAQ:APLS) -50%, Mersana Therapeuti...
HGEN - Hot Stocks: LULU earnings; Gun stocks rise; CURV reverses course again; SAM keeps falling; HGEN misses on COVID drug

The bulls missed the mark on Thursday, with the major averages finishing the session comfortably in negative territory. Still, one niche sector hit a bullseye amid the general losses -- gun and ammunition manufacturers. The sector gained ground after the Biden administration backed down ...

HGEN - INGN, MTEX and AVCT among mid-day movers

Gainers: Gevo (NASDAQ:GEVO) +35%. American Virtual Cloud Technologies (NASDAQ:AVCT) +33%. Rocket Lab (NASDAQ:RKLB) +32%. Torrid (NYSE:CURV) +30%. Montauk (NASDAQ:MNTK) +25%. Impel (NASDAQ:IMPL) +22%. Gold Royalty (NYSE:GROY) +22%. ProQR (NASDAQ:PRQR) +21%. Hyzon (NASDAQ:HYZN) +21%. Rockley (N...

HGEN - Here's Why Humanigen Is Getting Hammered Today

Humanigen (NASDAQ: HGEN) stock is sinking after the clinical-stage biopharmaceutical company shared devastating news. The FDA has declined Humanigen's request for emergency use authorization of lenzilumab, sending the biotech stock 52.1% lower as of 11:38 a.m. EDT on Thursday. ...
Previous 10 Next 10